Initiatives Seek To Reduce Salt Intake Among Blacks, Offer Health Benefits Assistance To Hispanics, Examine Caring For People With Alzheimer's Disease

Baltimore: The city in September will launch a six-month awareness campaign about salt intake associated with high blood pressure, particularly among blacks, the Baltimore Sun reports. According to the Sun, "In a city that is nearly 65% black, the risks of hypertension, which can lead to heart attack, kidney failure and stroke, are especially high. Read more ...

It all started because of failure, a missing person who couldn't be located in time. It was and still is a story that happens monthly, if not weekly all across our nation. For families and caregivers exploring options of how to protect a loved one who wanders away from the safety of their home due to Alzheimer's, Dementia, Autism, Intellectual Disabilities or other wandering conditions, there is hope. Read more ...

Cancer Research

Today the boundaries between medical and biological disciplines have vanished. . . . In an anatomy department, biologists, chemists, and physicists can present the human body to medical students as an uninterrupted ascent from atoms to man: from the tens of atoms that make a small molecule, to the thousands of molecules that make a polymer (such as a protein or a nucleic acid), to the millions of such polymers that make a cell, to the billions of cells that make a tissue, and the trillions of specialized cells that create a body.

Alternative Nonsteroidal Antiandrogen Therapy For Advanced Prostate Cancer That Relapsed After Initial Maximum Androgen Blockade

UroToday.com - In the September, 2008 issue of the Journal of Urology, Dr. Hiroyoshi Suzuki and Japanese collaborators reported that following maximum androgen blockade (MAB) for prostate cancer (CaP), the use of alternative nonsteroidal antiandrogens is effective for treating relapsed disease. A total of 232 CaP patients treated with MAB and disease progression made up the study cohort. Upon disease relapse they were treated with an alternative antiandrogen. Continue reading ...

UroToday.com - The practice of lymphadenectomy during radical cystectomy for muscle invasive bladder cancer is not standardized. There is a wide variation in the number of nodes retrieved. Recent studies suggest that both the number of nodes removed and the method of submission of lymph node specimens affect the treatment outcome. Continue reading ...

Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) subsidiary Systems Medicine (SM) has announced that planned enrollment is complete in the European Organization for Research and Treatment of Cancer (EORTC) randomized phase II clinical trial of brostallicin in patients with newly diagnosed advanced or metastatic soft tissue sarcoma who have had no prior chemotherapy. The primary endpoint of the trial is progression-free survival at six months. Continue reading ...